Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy.

Am J Hematol · 2026 · PMC12869000 · PMID 41492073

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

NT‐proBNP levels increased during induction therapy from a baseline median of 139 [IQR 55.7–336] to 166.5 ng/L [IQR 72–408.1] at Day 15 ( n = 150; Figure 1B ), although this change did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.